Description
KGDS is a synthetic peptide derived from fibrinogen. KGDS activates the glycoprotein IIb/IIIa receptor, inhibiting fibrinogen-platelet binding and thrombin activity.
KGDS is a synthetic peptide derived from fibrinogen. KGDS activates the glycoprotein IIb/IIIa receptor, inhibiting fibrinogen-platelet binding and thrombin activity.
| Purity | ≥95% |
|---|---|
| Formula | C15H27N5O8 |
| Formula Wt. | 405.41 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Knapp A, Degenhardt T, Dodt J. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity. J Biol Chem. 1992 Dec 5;267(34):24230-4. PMID: 1447173.
Parise LV, Helgerson SL, Steiner B, et al. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. J Biol Chem. 1987 Sep 15;262(26):12597-602. PMID: 2957377.
β2-adrenergic agonist.
Nonpeptide angiotensin II receptor antagonist
Induces activation of Nrf2; inhibits apoptosis ...
Mixture of terpene lactones found in Ginkgo.
Prenylflavinoid, derivative of xanthohumol foun...
Alkaloid found in Fabaceae family plants; α3β...
Catechol-type flavonoid; fatty acid synthesis i...
SARS-CoV-2 inhibitor
Amphiphilic properties
S-isomer of omeprazole; H+/K+ ATPase inhibitor....
JAK1 inhibitor.
CDK inhibitor, L-type Ca2+ channel blocker.
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Caffeic acid derivative.
Endogenous peptide hormone fragment, involved i...
MET inhibitor.
p110α and p110γ PI3K inhibitor.
Tyrphostin; VEGFR inhibitor.
Protein translation inhibitor, peptidyl transfe...
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...